Valley Cottage, NY — (PRESS RELEASE JET) — 09/27/2017 — Octreotide are amino acid monomer which is attached to amide group. The octreotide acts similar to the hormone somatostatin. Octreotide basically lowers the variety of hormone such as insulin, glucagon, growth hormone and others, Octreotide reduces chemical messengers such as gastrin, vasoactive intestinal peptide that cause disease symptoms. Octreotide depending upon the severity generally severe diarrhea, acromegaly as well as for treating flushing in patients with tumors. Octreotride is also used to reduction of the side effects from cancer chemotherapy. The global Octreotide market was estimated to be around U.S $ 1.6 Bn. in 2013 .The estimated CAGR for Octreotide market from 2012 to 2013 was approximately 5%. The use of octreotide is expected to grow because of increase in number of people diagnosed with cancer, diarrhea and tumors.
Octreotide Market: Drivers and Restraints
The global demand for octreotide is driven by growing number of people under the diagnosis of cancer. In 2012, there were estimated 14.1 million cases of cancer .It is estimated that by 2035, the number of people suffering from cancer will be around 24 million. These estimate shows that the demand for treatment drugs such as octreotide will grow. It is forecasted that around 2200 children die every day due to severe diarrhea, more than Aids, malaria and measles combined. Henceforth it is important to tackle these world challenges by supplying adequate octreotide drugs for the diseased. The use of octreotide in radiolabelling will substantially increase the demand for Octreotide.
The increasing popularity of generic drugs might affect the consumption of branded drugs. The availability of generic drugs is expected to grow because of cost factor and hence will affect the overall Pharmaceutical industry if not restructured according to the market and consumer needs. The important restraining factor for Octreotide Market is the lack research of Octreotide for the treatment of children, pregnant and lactating women. The use of Octreotide is based on risk factor analysis hence might affect the consumption of Octreotide.
Octreotide Market: Segmentation
On the basis of Type, global Octreotide Market is segmented into:
indium In-111; octreotide
On the basis of End use, global Octreotide Market is segmented into:
Octreotide Market: Key market Players
Some of the Octreotide producers are Novartis pharmaceuticals corp., App pharmaceuticals llc, Bedford laboratories div ben venue laboratories Inc., Sun pharmaceutical industries ltd., Sinopharm A-THINK Pharmaceutical Co., Ltd., Teva parenteral medicines Inc., Neiss Labs Pvt. Ltd., Samarth Pharma Pvt. Ltd. J.B. Chemicals and Pharmaceuticals Ltd and others
Powered by WPeMatico